Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Semerjian

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
The Prostate|April 25, 2022
The added influence of genomics and post-MRI confirmatory biopsy results to MRI results alone on medical decision making for men with favorable risk prostate cancer being considered for active surveillanceMichael Wang, Ji Qi, Arvin K George, et al.
Urologic Oncology|June 17, 2019
Surgical removal of renal tumors with low metastatic potential based on clinical radiographic size: A systematic review of the literatureHiten D Patel, Alice Semerjian, Mohit Gupta, et al.
Urologic Oncology|October 4, 2017
Incidence of T3a up-staging and survival after partial nephrectomy: Size-stratified rates and implications for prognosisArnav Srivastava, Hiten D Patel, Gregory A Joice, et al.
The Journal of Urology|October 20, 2022
The Use and Short-term Outcomes of Active Surveillance in Men With National Comprehensive Cancer Network Favorable Intermediate-risk Prostate Cancer: The Initial Michigan Urological Surgery Improvement Collaborative ExperienceRoshan Paudel, Raghav Madan, Ji Qi, et al.
The Journal of Urology|October 21, 2022
Reply by AuthorsRoshan Paudel, Raghav Madan, Ji Qi, et al.
The Prostate|May 12, 2023
Upgrading on Per Protocol versus For Cause surveillance prostate biopsies: An opportunity to decreasing the burden of active surveillanceMichael Wang, Andrew Lange, David Perlman, et al.
Plos One|June 15, 2016
Tumor and Plasma Met Levels in Non-Metastatic Prostate CancerDeborah R Kaye, Peter A Pinto, Fabiola Cecchi, et al.
The Journal of Urology|July 7, 2020
Development of a Novel Scoring System Quantifies Opportunities to Reduce Surgery for Benign Renal Neoplasms: A Retrospective Quality Improvement Analysis within the MUSIC-KIDNEY CollaborativeHenry Peabody, Amit Patel, Anna Johnson, et al.
Urology Practice|June 24, 2024
Uptake of Same-Day Discharge for Patients Undergoing Robot-Assisted Radical Prostatectomy in the Michigan Urological Surgery Improvement CollaborativeGolena Fernandez Moncaleano, Michael Levin, Sabir Meah, et al.
Urology Practice|August 20, 2024
Reply by AuthorsGolena Fernandez Moncaleano, Michael Levin, Sabir Meah, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
The Prostate|April 25, 2022
The added influence of genomics and post-MRI confirmatory biopsy results to MRI results alone on medical decision making for men with favorable risk prostate cancer being considered for active surveillanceMichael Wang, Ji Qi, Arvin K George, et al.
Urologic Oncology|June 17, 2019
Surgical removal of renal tumors with low metastatic potential based on clinical radiographic size: A systematic review of the literatureHiten D Patel, Alice Semerjian, Mohit Gupta, et al.
Urologic Oncology|October 4, 2017
Incidence of T3a up-staging and survival after partial nephrectomy: Size-stratified rates and implications for prognosisArnav Srivastava, Hiten D Patel, Gregory A Joice, et al.
The Journal of Urology|October 20, 2022
The Use and Short-term Outcomes of Active Surveillance in Men With National Comprehensive Cancer Network Favorable Intermediate-risk Prostate Cancer: The Initial Michigan Urological Surgery Improvement Collaborative ExperienceRoshan Paudel, Raghav Madan, Ji Qi, et al.
The Journal of Urology|October 21, 2022
Reply by AuthorsRoshan Paudel, Raghav Madan, Ji Qi, et al.
The Prostate|May 12, 2023
Upgrading on Per Protocol versus For Cause surveillance prostate biopsies: An opportunity to decreasing the burden of active surveillanceMichael Wang, Andrew Lange, David Perlman, et al.
Plos One|June 15, 2016
Tumor and Plasma Met Levels in Non-Metastatic Prostate CancerDeborah R Kaye, Peter A Pinto, Fabiola Cecchi, et al.
The Journal of Urology|July 7, 2020
Development of a Novel Scoring System Quantifies Opportunities to Reduce Surgery for Benign Renal Neoplasms: A Retrospective Quality Improvement Analysis within the MUSIC-KIDNEY CollaborativeHenry Peabody, Amit Patel, Anna Johnson, et al.
Urology Practice|June 24, 2024
Uptake of Same-Day Discharge for Patients Undergoing Robot-Assisted Radical Prostatectomy in the Michigan Urological Surgery Improvement CollaborativeGolena Fernandez Moncaleano, Michael Levin, Sabir Meah, et al.
Urology Practice|August 20, 2024
Reply by AuthorsGolena Fernandez Moncaleano, Michael Levin, Sabir Meah, et al.
Pageof 5